Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome

导出原文传递

翻译打印收藏纠错

作者： Gautier-Veyret, Elodie ^[1] ; Back, Magnus ^[2] ; Arnaud, Claire ^[3] ; Belaidi, Elise ; Tamisier, Renaud ; Levy, Patrick ; Arnol, Nathalie ; Perrin, Marion ; Pepin, Jean-Louis ; Stanke-Labesque, Francoise

作者单位： Karolinska Inst, Dept Med, Stockholm, Sweden ^[1] Univ Grenoble Alpes, HP2, F-38041 Grenoble, France ^[2] Ctr Hosp Univ Alpes, F-38043 Grenoble, France ^[3]

关键词 Obstructive sleep apnea Leukotrienes Atherosclerosis Intermittent hypoxia Pharmacology

发布时间 2019-02-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Pharmacological research

2018年134卷

311-319页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome

Pharmacological research

相似文献

Pharmacological research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome

Pharmacological research

相似文献

Pharmacological research

相关期刊

检索历史清除